Gene therapy animation

SCIENTIFIC ANIMATION | Website assets and scientific education

UniQure is investigating the potential of gene transfer to cure patients with genetic disorders. Viruses are used to deliver normal copies of a gene to cells, enabling the production of functioning proteins and potentially curing genetic disorders such as cystic fibrosis. This new genetic material is not integrated into the DNA and so is not passed onto future generations.

The educational animation developed by Random42 sits on the UniQure website and demonstrates to a wider audience how gene transfer technology functions within the body.

Are you interested in seeing how our award-winning medical animation can help you?

Random42 constantly strives to innovate in the medical animation space. Get in touch for a consultation on your next project.

TESTIMONIALS

cellectar logo

‘‘Extremely happy, everybody was great on the team. They answered all our questions and made it look easy. The end result is perfect.

Executive Coordinator, Cellectar Biosciences

vallum-logo

‘‘The presentation was dramatically enhanced by the video, which looked fantastic on the big screen. Thank you and the entire Random42 team for your excellent work and for getting the final edition to me in time for the conference. All very much appreciated!

President and CEO, Vallum Corporation

brainstorm-logo

‘‘The quality of the work produced by Random42 sets them apart and helps us quickly tell our scientific story more clearly. The high-quality production value is bolstered by their depth of knowledge. Together, that helps us tell the story of a complex disease and cell-based treatment and make it understandable to professionals and laypeople alike.’’

CEO, Brainstorm Cell Therapeutics

Phathom logo

‘‘Working with the Random42 team was a seamless collaboration, where they exhibited great project management skills, clear & thoughtful communication, and delivered high-quality work that was visually appealing. Our team was impressed with the final products!’’

Medical Affairs, Phathom Pharmaceuticals